Document:

<PAGE>

                                                                    Exhibit 10.3

                                    AMENDMENT

                                       TO

                          SHELF REGISTRATION AGREEMENT

         AMENDMENT TO SHELF REGISTRATION AGREEMENT, dated as of June 10, 2004
(the "Amendment"), by and between Endo Pharmaceuticals Holdings Inc., a Delaware
corporation (the "Company") and Endo Pharma LLC, a Delaware limited liability
company (the "LLC"). The Company and the LLC are collectively referred to herein
as the "Parties."

         WHEREAS, the Parties have entered into that certain Shelf Registration
Agreement, dated as of April 30, 2004 (the "Shelf Agreement");

         WHEREAS, on April 30, 2004, the Company filed a Registration Statement
on Form S-3 with the Securities and Exchange Commission to register 30 million
shares of the Company's common stock, par value $.01 (the "Common Stock") for
resale by the LLC and other stockholders of the Company (the "Shelf Registration
Statement");

         WHEREAS, the Shelf Registration Statement provides that the Selling
Stockholders (as defined below) will only sell the Common Stock being offered
thereby to underwriters for resale to the public or institutional investors;

         WHEREAS, the Company will file an amendment to the Shelf Registration
Statement (the "Shelf Registration Amendment") to include block sales,
derivative transactions with third parties and other types of hedging
transactions as potential methods by which the Selling Stockholders may sell the
Common Stock being offered thereby; and

         WHEREAS, the Parties desire to enter into this Amendment in order to
make necessary changes to the Shelf Agreement to reflect certain changes made to
the Shelf Registration Statement in the Shelf Registration Amendment.

         NOW, THEREFORE, in consideration of the mutual promises and obligations
of the Parties set forth in this Amendment, the Parties hereto agree to amend
the Shelf Agreement as follows:

         1. Section 1.1 of the Shelf Agreement is hereby deleted in its entirety
and the following new Section 1.1 will be added:

         "Section 1.1 Shelf Registration Agreement. The Company agrees to file
with the Commission a Shelf Registration Statement to register 30 million shares
of the Company's Common Stock, which will include up to 29,674,000 shares of
Common Stock for resale by the LLC (including shares to be sold on behalf of its
members) and 326,000 shares of Common Stock for resale by other stockholders of
the Company, as determined by the Company and the LLC (collectively, the
"Selling Stockholders"), to be sold, from time to time, in one or more of the
following types of transactions: (i) underwritten offerings; (ii) block
transactions; (iii) derivative transactions with third parties; or (iv) other
types of hedging transactions (each a "Take-down Transaction"). The Company has
no obligation to ensure that the Shelf Registration Statement is declared
effective by the Commission."

<PAGE>

         2. Section 1.3 of the Shelf Agreement is hereby deleted in its entirety
and the following new Section 1.3 will be added:

         "Section 1.3 Procedures for Shelf Registration. The Company and the LLC
agree that the procedures for any Take-down Transaction will be in conformity
with those set forth in the Registration Rights Agreement, the Employee
Stockholders Agreement and the Stockholders Agreement and shall apply to any
sales of Common Stock sold in a Take-down Transaction and that the provisions
set forth in Section 3(h), the paragraph immediately following Section 3(o) and
the last paragraph of Section 3 of the Registration Rights Agreement shall apply
to the Shelf Registration Statement."

                                       2

<PAGE>

         IN WITNESS WHEREOF, the parties hereto have duly executed this
Amendment as of the date first written above.

                                     ENDO PHARMA LLC

                                     By:  /s/ Michael B. Goldberg
                                         ----------------------------------
                                         Name: Michael B. Goldberg
                                         Title: Manager

                                     ENDO PHARMACEUTICALS HOLDINGS, INC.

                                     By:  /s/ Jeffrey R. Black
                                         ----------------------------------
                                         Name: Jeffrey R. Black
                                         Title: Executive Vice President,
                                                Chief Financial Officer and
                                                Treasurer

                                       3<PAGE>

                                                                    Exhibit 10.1

                                                    April 14, 2004

Dear Paul:

         Further to our conversations, I am pleased to confirm the principal
terms of your employment with Take-Two Interactive Software, Inc. ("T2"):

        Term:                    Three years

        Start Date:              April 14, 2004

        Title:                   President and Director

        Reporting:               Chairman and Interim Chief Executive Officer

        Salary:                  $600,000 per annum, payable bi-weekly in
                                 accordance with T2's normal payroll practices.

        Equity:                  300,000 non-plan options at an exercise price
                                 equal to the closing price of T2's Common
                                 Stock as reported by Nasdaq on April 14,
                                 2004 (vesting as to the initial 50,000
                                 shares six months after April 14, 2004 and
                                 the balance of the shares vesting in 50,000
                                 share lots every six months). T2 shall
                                 register the shares underlying the options
                                 under the Securities Act of 1933.

        Bonus:                   Quarterly bonus of $50,000 commencing with the
                                 quarter ended July 31, 2004; provided that
                                 T2 achieves its revenue and net income
                                 forecasts. In addition, signing bonus of
                                 $150,000.

        Car Allowance:           $1,000 per month.

        Benefits:                All benefits offered by T2 to executives of
                                 similar status, including 401(k) and Health
                                 Insurance. T2 shall pay the premiums on your
                                 life insurance in the amount of $1 million.

<PAGE>

        Termination:             Termination provisions substantially similar to
                                 those set forth under Employment Agreement
                                 dated July 2000 (the "Old Agreement").

        Reviews:                 Performance review on an annual basis.

        Vacation:                Four weeks.

         We will prepare a mutually acceptable employment agreement to reflect
the foregoing, which will contain provisions no less favorable to Employee than
as set forth in the Old Agreement. Until such agreement is executed and
delivered, this agreement shall be binding between the parties. Upon the
execution of this agreement, the Separation Agreement dated June 4, 2003 shall
automatically terminate (except for provisions of Section 6 of the Separation
Agreement which shall survive such termination).

         Paul, we look forward to you joining the Take-Two team.

                                                        Sincerely,

                                                        /s/ Richard Roedel
                                                        ------------------
                                                        Richard Roedel
                                                        Chairman and Interim CEO

AGREED and ACCEPTED:

/s/ Paul Eibeler
----------------
Paul Eibeler

                                       2<PAGE>

                                                                    Exhibit 10.2

                                                    April 14, 2004

Dear Gary:

         Further to our conversations, I am pleased to make the following offer
with respect to the terms of your employment with Take-Two Interactive Software,
Inc. ("T2"):

        Term:                    Two years

        Start Date:              April 14, 2004

        Title:                   Global Chief Operating Officer

        Reporting:               Interim Chief Executive Officer

        Salary:                  $600,000 per annum, payable bi-weekly in
                                 accordance with T2's normal payroll practices.

        Equity:                  145,000 options at an exercise price
                                 equal to the closing price of T2's
                                 Common Stock as reported by Nasdaq on
                                 April 14, 2004 (vesting as to 25,000
                                 shares on October 14, 2004; 60,000
                                 shares on April 14, 2005; and 60,000
                                 shares on April 14, 2006).

                                 Grant of 20,000 shares of restricted
                                 common stock (vesting 10,000 shares
                                 on April 14, 2005 and 10,000 shares
                                 on April 14, 2006).

        Relocation               Reimbursement of moving expenses to and from
        Allowance:               New York (not to exceed $50,000 for each move),
                                 interim housing allowance and payment of rent
                                 during the term.

        Bonus:                   Annual bonus of up to $600,000 based
                                 on mutually agreeable quantitative
                                 and qualitative performance targets,
                                 of which $150,000 is payable November
                                 1, 2004. Signing bonus of $500,000,
                                 of which $250,000 is payable upon the
                                 execution of this agreement and
                                 $250,000 is payable November 1, 2004.
<PAGE>

        Car Allowance:           $1,300 per month.

        Benefits:                All benefits offered by T2 to executives of
                                 similar status, including 401(k) and Health
                                 Insurance for you and your family. You shall
                                 be entitled to maintain your UK pension
                                 benefits. You and your family will be
                                 entitled to be reimbursed for travel
                                 expenses (Business Class) to the United
                                 Kingdom at least three times a year.

        Termination:             You shall be entitled to salary, bonus (if
                                 earned) and benefits for a period of
                                 eighteen months following the date of the
                                 termination of your employment without cause
                                 or upon a change of control or if you
                                 terminate your employment for good reason
                                 (i.e., a substantial and material diminution
                                 in your responsibilities, duties, reporting
                                 relationship or position) (in the case of a
                                 change of control, you will be entitled to a
                                 lump-sum payment), and in any such event all
                                 of your shares of restricted stock and
                                 options shall vest immediately.

        Reviews:                 Performance review on an annual basis.

        Vacation:                Five weeks.

         We will prepare a mutually acceptable employment agreement to reflect
the foregoing, which will contain customary provisions for an agreement of this
type (including mutually acceptable termination, confidentiality,
non-competition and non-solicitation provisions). Such agreement shall also
provide that T2 will make available to you a qualified tax advisor. In this
regard, the parties also agree to continue to negotiate in good faith whether
notice provisions are applicable and whether you shall become an employee of T2
or Take-Two Europe (although it is the current intention of the parties as
evidenced by this agreement that you will continue to be employed directly by T2
and that any employment agreement relating to your employment will be governed
under New York law). Until the execution of such agreement, the terms of this
agreement shall serve as the entire agreement between the parties. Upon the
execution of this agreement, all prior agreements and understandings between us
(including without limitation, your current employment agreement dated March 12,
2002 with Take-Two Europe) shall terminate.

                                       2
<PAGE>

         We understand that you have agreed to make a commitment of at least
six-months to remain in the employ of T2 as Global COO. Accordingly, as a
further inducement for you to enter into this agreement, in the event that you
voluntarily terminate your employment with T2 after October 14, 2004, you may
return to your current position with Take-Two Europe under the terms and
conditions of a mutually satisfactory long-form employment agreement to be
governed under the laws of the United Kingdom. In such event, 30,000 options
shall vest and become immediately exercisable, in addition to the 25,000 options
that vest on October 14, 2004 (provided that the balance of the unvested options
and any unvested restricted stock shall lapse) and you will be entitled to an
additional $100,000 of annual salary and an annual option grant of 30,000 shares
under the terms of such long-form employment agreement.

         Gary, we look forward to you joining the Take-Two team.

                                    Sincerely,

                                    /s/ Richard Roedel
                                    ------------------
                                    Richard Roedel
                                    Chairman and Interim Chief Executive Officer

AGREED and ACCEPTED:

/s/ Gary Lewis
--------------
Gary Lewis

                                       3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}]]